EML (peer comparison)
- 1800m approx market valuation
- revenue 180m,
- EBITDA of 50m (conservative case).
NOV
- $0.36 per share
- 82m market cap
- 30m revenue (based on last quarter * 4)
- Not yet turning a profit.
This will outperform the coming days/weeks/months return wise.
I see NOV being currently valued at least at 300m market cap, which equates to $1.32 per share.
Let the market wake up on this gem
